How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Ashkenazi has been key to managing the windfall in revenue and wave of investor optimism from Eli Lilly's diabetes injection
Read MoreAshkenazi has been key to managing the windfall in revenue and wave of investor optimism from Eli Lilly's diabetes injection
Read MoreNearly 75% of patients who took the cancer vaccine and Keytruda were alive without any signs or symptoms of their
Read MoreThe decision is a win for Moderna, which needs another revenue source amid plunging demand for its Covid vaccine, its
Read MoreThe company's medicine helped patients live longer without seeing their cancer progress, as most of them experienced that benefit for
Read MoreThe tracker could be a valuable tool for Americans scrambling to find GLP-1s, such as Novo Nordisk's weight loss injection
Read MoreThe votes at the CVS stores signal growing momentum in a movement to help thousands of U.S. pharmacy workers address
Read MoreA strain of bird flu called H5N1 has been confirmed in dairy cows in nine U.S. states, along with two
Read MoreThe weekly injection helped patients with obesity lose 18.8% of their weight relative to those who received a placebo, after
Read MoreNovavax said the deal with Sanofi allows it to remove its "going concern" warning, which it first issued last year
Read More